Monte Rosa Therapeutics Inc (GLUE)
6.91
+0.40
(+6.14%)
USD |
NASDAQ |
Dec 20, 16:00
6.915
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Enterprise Value: 182.34M for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Novartis AG | 210.57B |
| MEI Pharma Inc | -10.25M |
| Evoke Pharma Inc | 1.225M |
| Revance Therapeutics Inc | 570.21M |
| Vera Therapeutics Inc | 2.387B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.86M |
| Revenue (Quarterly) | 9.216M |
| Total Expenses (Quarterly) | 35.74M |
| EPS Diluted (Quarterly) | -0.29 |
| Profit Margin (Quarterly) | -258.9% |
| Earnings Yield | -26.48% |